Jinan Hi-Tech announcement, the company's wholly-owned subsidiary Jinan Hi-tech plans to contribute 229 million yuan, Jigao Finance plans to contribute 139 million yuan, and Ji Goldman Sachs Group and he plans to contribute 136 million yuan to acquire 60% of the shares held by Xilong Science. Jigao will hold 27.22% of Ackway Biology, and at the same time Xilong Science entrusts the remaining 13.78% of its equity voting rights to Jigao Industry to exercise on its behalf. Xilong Science promises that during the period of Ackway's biological performance commitment, the accumulated after-tax net profit after audit is not less than 190 million yuan. Through the acquisition of Eckway Biology, the company will bring the new main business of biomedicine to the company and realize the reform and optimization of the company's business structure.